MOORE CAPITAL MANAGEMENT, LP - SYNERGY PHARMACEUTICALS DEL ownership

SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 170 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q1 2017. The put-call ratio across all filers is 1.82 and the average weighting 0.1%.

Quarter-by-quarter ownership
MOORE CAPITAL MANAGEMENT, LP ownership history of SYNERGY PHARMACEUTICALS DEL
ValueSharesWeighting
Q1 2018$229,000
-54.4%
125,000
-44.4%
0.01%
-44.4%
Q4 2017$502,000
-23.1%
225,0000.0%0.01%
-30.8%
Q3 2017$653,000
-34.8%
225,0000.0%0.01%
-58.1%
Q2 2017$1,001,000
-4.6%
225,0000.0%0.03%
+10.7%
Q1 2017$1,049,000
-72.2%
225,000
-66.2%
0.03%
-76.1%
Q4 2015$3,771,000
+216.1%
665,000
+195.6%
0.12%
+108.9%
Q3 2015$1,193,000
-55.8%
225,000
-30.8%
0.06%
-3.4%
Q2 2015$2,698,000325,0000.06%
Other shareholders
SYNERGY PHARMACEUTICALS DEL shareholders Q1 2017
NameSharesValueWeighting ↓
Nantahala Capital Management 11,578,568$20,147,0000.82%
Virtus ETF Advisers LLC 441,461$768,0000.68%
Hikari Power Ltd 2,300,000$4,002,0000.44%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,403,149$2,441,0000.17%
KNOTT DAVID M 225,400$392,0000.15%
Clear Harbor Asset Management, LLC 277,110$482,0000.09%
Malaga Cove Capital, LLC 97,264$169,0000.09%
Lehman Financial Resources, Inc. 80,800$140,0000.07%
Cheyne Capital Management (UK) LLP 50,000$87,0000.06%
Ballew Advisors, Inc 26,200$46,0000.05%
View complete list of SYNERGY PHARMACEUTICALS DEL shareholders